Investigation of language improvement in aphasia using the app neolexon Aphasie” as a home exercise supplement

Not Applicable

• Conditions: R47.0; R48.2; Dysphasia and aphasia; Apraxia

• Registration Number: DRKS00026233
• Lead Sponsor: imedix GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-28
• Study Completion: 2023-10-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 196

Inclusion Criteria

Gender: w, m, d; Age: 18 years and older; Residence: Germany; Sufficient, premorbid language level in German (business fluent); Diagnosis: aphasia and/or apraxia of speech after brain injury (determined by physician/therapist); Aphasia diagnosed by BIAS-R is present; Post-onset time: 4 weeks or more; Has never used neolexon aphasia in selftraining; Has access to a computer/tablet and Internet; Receives (regular) standard speech and language therapy

Exclusion Criteria

Severe visual impairments such that images and text cannot be interpreted on a screen; severe motor restrictions that prevent the use of a tablet / computer; severe hearing impairments that impair ability to perceive auditory stimuli/instructions; severe cognitive impairments, which prevent the use of a tablet / computer; has used neolexon Aphasia in the past or is currently using neolexon Aphasia for digital home exercises

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bielefelder Aphasie Screening Reha (BIAS-R total score) conducted by the therapist 90 days post intervention

Secondary Outcome Measures

Name	Time	Method
Assessment of communication skills in the BIAS-R; Communicative Effectiveness Index (CETI total score); General Health Questionnaire 12 (GHQ-12 total score); EQ-5D-5L (index score as well as VAS score).